Roche acquiring Ignyta for $1.7B

Roche (SIX:ROG; OTCQX:RHHBY) is acquiring cancer company Ignyta Inc. (NASDAQ:RXDX) for $27 per share, or $1.7 billion, in cash. The price is a 74% premium to Ignyta's close Thursday of

Read the full 304 word article

User Sign In